Cite
MLA Citation
Anita Kohli et al.. “Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study.” Lancet infectious diseases, vol. 15, no. 9, n.d., pp. 1049–1054. http://access.bl.uk/ark:/81055/vdc_100070757508.0x000022